13F filer · CIK 914208 ↗
Invesco Ltd.
You are looking at Q4 2017. See the latest, Q2 2026 →
Reported value
$277.31B
+2.4% on the quarter before
Positions
3,638
132 new · 138 sold out
Top 10
16.3%
of the value
Est. gain
+$12.50B
on stocks held all quarter
Est. return
+5.0%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Invesco Ltd.'s 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 24% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jd Com Inc~$327.6MAdded · 0.2% → 0.3%+7,908,092 shares
- Meta~$283.4MAdded · 1.6% → 1.7%+1,606,309 shares
- Apple~$253.7MAdded · 2.7% → 3.0%+1,498,868 shares
- Asml Holding N V~$244.9MAdded · 0.0% → 0.1%+1,409,005 shares
- Tapestry Inc~$230.0MNew · 0.0% → 0.1%+5,199,292 shares
- Baker Hughes~$207.2MAdded · 0.1% → 0.2%+6,548,523 shares
- American Tower~$196.9MAdded · 0.3% → 0.3%+1,380,185 shares
- Aptiv Plc~$196.7MNew · 0.0% → 0.1%+2,319,199 shares
- Mckesson Corp~$190.9MAdded · 0.2% → 0.3%+1,224,251 shares
- Cvs Health Corp~$180.0MAdded · 0.2% → 0.3%+2,482,593 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Deutsche Bank A G~$1.20BSold out · 0.4% → 0.0%−11,400,000 shares
- Walgreens Boots Alliance Inc~$305.8MCut · 0.6% → 0.4%−4,210,701 shares
- Delphi Automotive Plc~$290.4MSold out · 0.1% → 0.0%−2,950,772 shares
- Abbvie Inc~$274.7MCut · 0.2% → 0.1%−2,840,560 shares
- Coach Inc~$226.1MSold out · 0.1% → 0.0%−5,613,942 shares
- Bank Amer Corp~$217.0MCut · 0.9% → 0.9%−7,351,749 shares
- IBM~$203.5MCut · 0.2% → 0.1%−1,326,150 shares
- Simon Ppty Group Inc New~$194.2MCut · 0.4% → 0.4%−1,130,824 shares
- Teva Pharmaceutical Inds Ltd~$188.4MCut · 0.1% → 0.0%−9,942,473 shares
- Suncor Energy Inc New~$186.1MCut · 0.6% → 0.6%−5,068,312 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +3.1% · price +9.8% | 3.0% | $8.38B | +$725.7M | ||||||||
| MicrosoftCOM · shares +1.7% · price +14.8% | 2.6% | $7.15B | +$908.0M | ||||||||
| AmazonCOM · shares +3.0% · price +21.6% | 2.2% | $6.04B | +$1.04B | ||||||||
| MetaCL A · shares +6.4% · price +3.3% | 1.7% | $4.69B | +$139.7M | ||||||||
| AlphabetCAP STK CL A · shares +1.4% · price +8.2% | 1.3% | $3.72B | +$277.3M | ||||||||
| AlphabetCAP STK CL C · shares +1.1% · price +9.1% | 1.3% | $3.63B | +$299.5M | ||||||||
| Citigroup IncCOM NEW · shares −4.4% · price +2.3% | 1.1% | $3.17B | +$71.1M | ||||||||
| CiscoCOM · shares −2.6% · price +13.9% | 1.1% | $3.04B | +$371.0M | ||||||||
| IntelCOM · shares +1.0% · price +21.2% | 0.99% | $2.73B | +$473.6M | ||||||||
| Bank Amer CorpCOM · shares −7.9% · price +16.5% | 0.91% | $2.53B | +$358.9M | ||||||||
| Comcast Corp NewCL A · shares +0.6% · price +4.1% | 0.90% | $2.49B | +$96.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares −5.9% · price +12.0% | 0.89% | $2.47B | +$264.4M | ||||||||
| Broadcom LtdSHS · shares −4.6% · price +5.9% | 0.66% | $1.82B | +$101.8M | ||||||||
| QualcommCOM · shares +2.6% · price +23.5% | 0.58% | $1.60B | +$297.4M | ||||||||
| Suncor Energy Inc NewCOM · shares −10% · price +4.8% | 0.58% | $1.60B | +$73.5M | ||||||||
| BaiduSPON ADR REP A · shares −6.0% · price −5.4% | 0.57% | $1.59B | −$91.6M | ||||||||
| Amgen IncCOM · shares −0.03% · price −6.7% | 0.57% | $1.58B | −$114.0M | ||||||||
| AlibabaSPONSORED ADS · shares −3.0% · price −0.2% | 0.54% | $1.51B | −$2.5M | ||||||||
| Pfizer IncCOM · shares +0.7% · price +1.5% | 0.52% | $1.43B | +$20.4M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −4.8% · price +7.1% | 0.49% | $1.36B | +$89.5M | ||||||||
| Celgene CorpCOM · shares +2.9% · price −28.4% | 0.47% | $1.31B | −$507.1M | ||||||||
| AT&TCOM · shares −2.7% · price −0.7% | 0.46% | $1.27B | −$9.5M | ||||||||
| Mondelez Intl IncCL A · shares +6.8% · price +5.3% | 0.46% | $1.27B | +$59.4M | ||||||||
| Philip Morris Intl IncCOM · shares +12% · price −4.8% | 0.46% | $1.26B | −$57.2M | ||||||||
| Gilead Sciences IncCOM · shares −1.5% · price −11.6% | 0.45% | $1.26B | −$164.6M | ||||||||
| Total · 3,638 positions | 100% | $277.31B | +$12.50B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 3,392 stocks held throughout, up $12.50B (+5.0%).
- Amazon+$1.04B+22%
- Microsoft+$908.0M+15%
- Apple+$725.7M+10%
- Intel+$473.6M+21%
- Cisco+$371.0M+14%
- Merck & Co Inc−$124.3M−12%
- General Electric Co−$149.0M−28%
- Gilead Sciences Inc−$164.6M−12%
- PPL Corporation−$169.4M−18%
- Celgene Corp−$507.1M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 7 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.26T+23% | SEC ↗ |
| Q1 2026 | May 12, 2026 (amended) | $1.02T−3% | SEC ↗ |
| Q4 2025 | Feb 19, 2026 (amended) | $1.06T+67% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $634.72B+8% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $587.99B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $527.93B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $540.90B+4% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $517.95B+10% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $472.84B+2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $465.56B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $420.24B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.30B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $381.45B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $358.48B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $341.42B+10% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $310.69B−6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $330.04B−16% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $392.05B−5% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $414.84B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $394.59B−3% | SEC ↗ |
| Q2 2021 | Aug 17, 2021 | $406.58B+9% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $374.71B+9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $343.59B+16% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $295.82B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $279.68B+18% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $237.58B−26% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $322.08B−16% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $382.36B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 (amended) | $388.53B+31% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $296.53B+14% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $261.24B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $317.79B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $302.15B+13% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $267.56B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $277.31B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.72B−16% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $321.34B+5% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $304.59B+2% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $297.54B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $291.04B+7% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $272.23B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $246.04B | SEC ↗ |